In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Euclises Pharmaceuticals Inc.

Latest From Euclises Pharmaceuticals Inc.

Start-Up Execs On The Move, February 2015

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Execs On The Move, February 2015

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device

The A-List: The Trend-Shaping Series A Financings Of 2014

In our 11th annual analysis of Series A financings, we look at five sub-species of A round investors, their habits, habitats, and behaviors during 2014.

BioPharmaceutical Medical Device

Out Of The Blocks, July-August 2012

Brief profiles of these recently formed companies: BriteSeed, Cool-Bio, Euclises Pharmaceuticals, Global Blood Therapeutics, Magenta Medical and Neviah Genomics.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Euclises Pharmaceuticals Inc.
  • Senior Management
  • Bobby W Sandage, Jr., PhD, Pres. & CEO
    Kathleen Larrimer Beckmann, CFO
    John Talley, PhD, CSO
    George Capps, Dir., Bus. Dev.
  • Contact Info
  • Euclises Pharmaceuticals Inc.
    Phone: (314) 690-1441
    4320 Forest Park Ave., BioGenerator
    Ste. 304
    St. Louis, MO 63108